Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Cell Expansion System

By Drug Discovery Trends Editor | June 17, 2010

Beckman Coulter, Inc., has entered into a strategic alliance with CaridianBCT, under the terms of which Beckman Coulter will market CaridianBCT cell therapy products in specific, targeted markets.

CaridianBCT and Beckman Coulter will launch CaridianBCT’s Quantum Cell Expansion System, a closed system that automates the cell expansion process, along with marketing CaridianBCT’s COBE 2991 Cell Processor, a system that washes and concentrates cell populations, and the Elutra Cell Separation System, which purifies cell populations via elutriation.

Adding the Quantum, Elutra and COBE 2991 systems to the Beckman Coulter line of products for cell sorting, cellular analysis and characterization will enable the company to provide pharmaceutical companies, research institutes and clinical trial organizations with a full line of cellular discovery systems.

“Beckman Coulter is pleased to have CaridianBCT as a strategic partner and values their expertise in cell processing and sterile, closed systems,” said Cynthia Collins, group vice president of Cellular Analysis at Beckman Coulter. “We are committed to being the leader in cell therapy tools, and with the addition of these three products to our portfolio of cell sorters, flow cytometers and reagents, we now provide an even wider selection of tools for cell therapy.”

“CaridianBCT has been enabling cell therapy applications around the world for over 30 years with proven systems that collect, separate, wash and concentrate human cells,” said Tom Jordan, senior vice president of Therapeutic Systems at CaridianBCT. “We are confident that Beckman Coulter’s broad market reach and product portfolio, coupled with our innovative systems, will further advance the field of cell therapy.”

CaridianBCT will retain the distribution rights to these cell therapy products in other market segments including commercial cell therapy developers, cell therapy contract manufacturing organizations, the veterinary market, and the cord-blood bank and blood bank markets.

Date: June 16, 2010
Source: Beckman Coulter, Inc. www.beckmancoulter.com


Filed Under: Drug Discovery

 

Related Articles Read More >

Roche in Drug Discovery & Development Pharma 50
Roche’s bispecific antibody Lunsumio wins priority review from FDA for non-Hodgkin lymphoma
Tiffany Hurd
CB Therapeutics biz dev lead sees upside for psychedelics in mental health and beyond
Pharmacovigilance
A new era of pharmacovigilance: Worldwide master key for drug safety monitoring
Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50